Figure 3
![Figure 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40880-015-0017-7/MediaObjects/40880_2015_17_Fig3_HTML.gif)
Kaplan-Meier subgroup analysis stratified according to TNM stage. A, for the 71 patients with TNM early-stage diseases (including stages I and II), the survival rate in the antiviral treatment group was significantly higher than that in the non-antiviral treatment group. B, for the 153 patients with TNM advanced stage diseases (including stages III and IV), there was no significant difference between the antiviral and non-antiviral treatment groups. TACE, transarterial chemoembolization; CI, confidence interval.